Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Adastra Holdings Ltd C.XTRX

Alternate Symbol(s):  XTXXF

Healthcare Drug Manufacturers - Specialty & Generic Cannabis Cannabis
Adastra Holdings Ltd. is a Canada-based company, which is engaged in the supply and manufacturing of ethnobotanical and cannabis products for lawful adult-use. The Company extracts and processes cannabis for sale to the recreational and medical markets in Canada using its large-scale extraction facility (the Facility) to produce a variety of products, including vape pens, wax, resin, infused... see more

CSE:XTRX - Post Discussion

Adastra Holdings Ltd > Receives Flower Sales License from Health Canada
View:
Post by Betteryear2 on Dec 20, 2021 1:01pm

Receives Flower Sales License from Health Canada

LANGLEY, BC, Dec. 20, 2021 /CNW/ - Adastra Holdings Ltd. (CSE: XTRX) (FRA: D2EP) ("Adastra" or the "Company") today announced that the Company's wholly-owned subsidiary Adastra Labs Inc. ("Adastra Labs") has received its flower sales license amendment from Health Canada effective December 17, 2021 (the "Flower Sales License"). The Flower Sales License will allow Adastra Labs to sell dried cannabis flower products provincially and territorially in Canada through authorized distributors and retailers.


https://www.newswire.ca/en/releases/archive/December2021/20/c8081.html
Comment by Gismo2020 on Jan 19, 2022 10:07am
There are two big investors in the bid who plundered their children's money box hoping for investors who would nee desperately a few dollars
Comment by TdotTechTrader on Feb 23, 2022 9:08pm
The risk reward on this one is out of whack. Flower license is a waste, they should focus on other parts of the value chain like $AYUR.
Adastra Holdings Ltd
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Dealroom for high-potential pre-IPO opportunities